CVE-2022-25631
CVE-2022-25631
Vexday Risk Score
21Low
SSVC decision (CISA)
Track
No exploitation signal → monitor
CVSS 7.8EPSS 0.2%KEV nãoPoC —Nuclei —Metasploit —Patch —
Lifecycle
20 Jan 2023Published on NVD
Recommendation: Monitor — no exploitation signal at the moment.
Symantec Endpoint Protection, prior to 14.3 RU6 (14.3.9210.6000), may be susceptible to a Elevation of Privilege vulnerability, which is a type of issue whereby an attacker may attempt to compromise the software application to gain elevated
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Affected products
n/a · Symantec Endpoint Protection